Nanoformulated Curcumin for Enhanced Cardioprotective and Antioxidant Activity Against Oxidative Stress
Oriental Journal Of Chemistry · 31.10.2026 · 5 (42) · 2123
DOI: 10.13005/ojc/420529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oriental Journal Of Chemistry, online erschienen am 30.10.2026. Verfasst von Deepak Singh Chaudhary und 8 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiovascular disease (CVD) remains the leading global cause of death, with oxidative stress as a central pathogenic driver. Curcumin, a natural polyphenol from Curcuma longa, exhibits potent antioxidant and cardioprotective properties through direct ROS scavenging, Nrf2 activation, and NF‑κB inhibition. However, its clinical translation is severely limited by poor aqueous solubility, rapid metabolism, and extremely low oral bioavailability. This study aimed to develop and evaluate nanoformulated curcumin using four different nanocarrier systems—PLGA nanoparticles (NPs), solid lipid nanoparticles (SLNs), liposomes, and nanoemulsions—to overcome these barriers and enhance cardioprotection against oxidative stress. All formulations were characterized for particle size (82–216 nm), zeta potential (−15 to −32 mV), encapsulation efficiency (>85%), and sustained in vitro release over 72 h. Based on overall performance, PLGA NPs were selected for further biological studies. In H9c2 and AC16 cardiomyocytes subjected to H₂O₂, doxorubicin, or oxygen‑glucose deprivation/reoxygenation (OGD/R), nanoformulated curcumin (Nano-Cur, 10 µM curcumin equivalent) significantly improved cell viability (85–90% vs. 45–50% in stressed controls) and reduced LDH release and trypan blue uptake compared to free curcumin. Nano-Cur also lowered intracellular ROS (DCFH‑DA and DHE fluorescence) by 70%, restored SOD, catalase, and GPx activities, and normalized the GSH/GSSG ratio. In an in vivo rat model of myocardial ischemia/reperfusion (I/R), intravenous Nano-Cur (5 mg/kg) reduced infarct size by 70% (to 14.2%), decreased serum troponin I by 80%, preserved left ventricular ejection fraction (72% vs. 48% in vehicle), and attenuated MDA, protein carbonyls, and 8‑oxodG levels. Mechanistically, Nano-Cur enhanced nuclear Nrf2 translocation and suppressed NF‑κB activation, leading to upregulation of HO‑1 and NQO1 and downregulation of TNF‑α and IL‑1β. These findings demonstrate that nanoformulation dramatically improves curcumin’s pharmacokinetic and pharmacodynamic profile, enabling robust cardioprotection against oxidative stress‑induced injury. Nanotechnology‑based delivery of curcumin represents a promising therapeutic strategy for ischemic heart disease, doxorubicin cardiotoxicity, and other oxidative cardiovascular disorders.
Zitieren
APA
Chaudhary, D. S., Bal, J., Sinha, A. K., Rathaur, H., Kumar, M., Adhau, S. A., Hivale, N. S., Sharma, R., & Rao, N. G. R. (2026). Nanoformulated Curcumin for Enhanced Cardioprotective and Antioxidant Activity Against Oxidative Stress. Oriental Journal Of Chemistry, 5(42), 2123. https://doi.org/10.13005/ojc/420529
Vancouver
Chaudhary DS, Bal J, Sinha AK, Rathaur H, Kumar M, Adhau SA, et al. Nanoformulated Curcumin for Enhanced Cardioprotective and Antioxidant Activity Against Oxidative Stress. Oriental Journal Of Chemistry. 2026;5(42):2123. doi:10.13005/ojc/420529
BibTeX
@article{Chaudhary2026,
author = {Chaudhary, Deepak Singh and Bal, Jyotiprava and Sinha, Akshay Kumar and Rathaur, Himanshi and Kumar, Mohit and Adhau, Shruti Anil and Hivale, Nitin Sukadev and Sharma, Rashmi and Rao, N. G. Raghavendra},
title = {Nanoformulated Curcumin for Enhanced Cardioprotective and Antioxidant Activity Against Oxidative Stress},
journal = {Oriental Journal Of Chemistry},
year = {2026},
volume = {5},
number = {42},
pages = {2123},
doi = {10.13005/ojc/420529}
}
EUVIMED